Cargando…
CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease
INTRODUCTION: The treatment with monosialotetrahexosylganglioside (GM1) improves the symptoms of Parkinson’s disease (PD). The alteration of DNA methylation in the blood was examined to investigate epigenetic modification by GM1 treatment. METHODS: After a 28-day continuous intravenous infusion of G...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264581/ https://www.ncbi.nlm.nih.gov/pubmed/37323142 http://dx.doi.org/10.3389/fnagi.2023.1122647 |